［１］Moussavi S, Chattlerji S, Verdes E, et al. Depression, chronic diseases, and decrements in health:results from the World Health Surveys［J］. Lancet, 2007, 370(95):851858.
［2］Rayner L, Price A, Evans A, et al. Antidepressants for depression in physically ill people［J］. Cochrane Database Syst Rev, 2010(3):CD007503.
［3］Slaughter JR, Slaughter KA. Prevalence, clinical manifestations, etiology, and treatment of depression in Parkinsons disease［J］. J Neuropsychiaty Clin Neurosci, 2001, 13(2):187196.
［4］Mitchell AJ, Rao S, Vaze A. Do primary care physicians have particular difficulty identifying latelife depression? A metaanalysis stratified by age［J］. Psychother Psychosom, 2010, 79(5):285294.
［5］黄世敬, 雷小明. 老年抑郁症发病机制的研究进展［J］. 医学综述, 2013, 19(1):14.
［6］张盛宇, 李霞. 老年抑郁症患病危险因素的研究进展［J］. 内科理论与实践, 2012, 7(2):133136.
［7］杨永秀, 潘冰. 帕金森病伴抑郁的诊治分析［J］. 中国康复理论与实践, 2009, 15(6):545547.
［8］McDonald WM, Richard IH, DeLong MR. Prevalence, etiology, and treatment of depression in Parkinsons disease［J］. Biol Psychiatry, 2003, 54(3):363375.
［9］Rihmer Z, Seregi K, Rihmer A. Parkinsons disease and depression［J］. Neuropsychopharmacol Hung, 2004, 6(2):8285.
［10］Reijnders JS, Ehrt U, Weber WE, et al. A systematic review of prevalence studies of depression in Parkinsons disease［J］. Mov Disord 2008, 23(2):183189.
［11］Gage H, Hendricks A, Zhang S, et al. The relative health related quality of life of veterans with Parkinsons disease［J］. J Neurol Neurosurg Psychiatry, 2003, 74(2):163169.
［12］Ehrt U, Brnnick K, Leentjens AFG, et al. Depressive symptom profile in Parkinsons disease:a comparison with depression in elderly patients without Parkinsons disease［J］. Int J Geriatr Psychiatry, 2006, 21(3):252258.
［13］Funkiewiez A, Ardouin C, Caputo E, et al. Long term effects of bilateral subthalamic nucleus stimulation on cognitive function, mood, and behaviour in Parkinsons disease［J］. J Neurol Neurosurg Psychiatry, 2004, 75:834839.
［14］陈涛, 唐北沙, 廖小平. α突触核蛋白在帕金森病发病机制中的作用［J］. 中华神经科杂志, 2006, 39(6):415418.
［15］梁炜, 张红梅, 张红云. 帕金森病伴发抑郁患者血小板5羟色胺浓度的对照研究［J］. 中国实用神经疾病杂志, 2009, 12(17):5051.
［16］石葛明, 樊平, 崔慧先, 等. 帕金森症患者脑标本5羟色胺转运体的表达［J］. 基础医学与临床, 2007, 27(3):263266.
［17］Remy P, Doder M, Lees A, et al. Depression in Parkinsons disease:loss of dopamine and noradrenaline innervation in the limbic system［J］. Brain, 2005, 128(6):13141322.
［18］Nagatsu T, Sawada M. Inflammatory process in Parkinsons disease:role for cytokines［J］. Current Pharma Des, 2005, 11(8):9991016.
［19］Matsui H, Nishinaka K, Oda M, et al. Depression in Parkinsons disease. Diffusion tensor imaging study［J］. J Neurol, 2007, 254(9):11701173.
［20］Cardoso EF, Maia FM, Fregni F, et al. Depression in Parkinsons disease:convergence from voxelbased morphometry and functional magnetic resonance imaging in the limbic thalamus［J］. Neuroimage, 2009,47(2):467472.
［21］Plhagen, SE, Ekberg S, Wlinder J, et al. HMPAO SPECT in Parkinsons disease (PD) with major depression (MD) before and after antidepressant treatment［J］. J Neurl, 2009, 256(9):15101518.
［22］Mayberg HS, Starkstein SE, Sadzot B, et al. Selective hypometabolism in the inferior frontal lobe in depressed patients with Parkinsons disease［J］. Ann Neurol, 1990, 28(1):5764.
［23］Kalbe E, Calabrese P, Kohn N, et al. Screening for cognitive deficits in Parkinsons disease with the Parkinson neuropsychometric dementia assessment (PANDA) instrument［J］. Parkinsonism Relat Disord, 2008, 14(2):93101.
［24］Inoue T, Kitagawa M, Tanaka T, et al. Depression and major depressive disorder in patients with Parkinsons disease［J］. Mov Disord, 2010, 25(1):4449.
［25］Williams JR,Hirsch ES,Anderson K,et al.A comparison of nine scales to detect depression in Parkinson disease:which scale to use?［J］. Neurology, 2012, 78(13):9981006.
［26］Okun MS, Fernandez HH. Will tricyclic antidepressants make a comeback for depressed Parkinson disease patients?［J］. Neurology, 2009, 72(10):868869.
［27］Menza M, Dobkin RD, Marin H, et al. A controlled trial of antidepressants in patients with Parkinson disease and depression［J］. Neurology, 2009, 72(10):886892.
［28］Devos D, Dujardin K, Poirot I, et al. Comparison of desipramine and citalopram treatments for depression in Parkinsons disease:A doubleblind, randomized, placebocontrolled study［J］. Mov Disord, 2008, 23(6):850857.
［29］梅海云, 胡法富, 周秀丽,等. 舍曲林治疗帕金森病伴发抑郁症状患者的临床研究［J］. 中国现代医学杂志,2010,13(7):20502052.
［30］冯艳, 袁丽品, 李燕. 帕罗西汀治疗帕金森病抑郁状态的疗效观察［J］. 中国老年学杂志, 2011, 31(12):23222323.
［31］Gimenez RS, Dobato JL, Mateo D. Treatment of depression in Parkinsons disease with moclobemide:A pilot openlabel study［J］. Parkinsonism Relat Disord, 1997, 3(4):219225.
［32］Barone P, Poewe W, Albrecht S, et al. Pramipexole for the treatment of depressive symptoms in patients with Parkinsons disease:a randomised, doubleblind, placebocontrolled trial［J］. Lancet Neurol, 2010, 9(6):573580.